Latest news
Professor Andrew Lotery answers your questions
Posted: Wednesday 5 March 2025
Professor Andrew Lotery discusses the latest approved treatment for wet age-related macular degeneration (AMD), Lytenava and answers your frequently asked questions on treatments and research.
Find out more
Gene therapy trial improves sight in blind toddlers
Posted: Tuesday 4 March 2025
Four toddlers born with a severe form of childhood blindness have experienced “life-changing improvements” to their sight after participating in an experimental gene therapy trial.
Find out more
Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment
Posted: Thursday 30 January 2025
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.
Find out more
First treatment for late-stage dry AMD rejected by UK drug regulator
Posted: Wednesday 22 January 2025
The first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration has been rejected by the Medicines and Healthcare products Regulatory Agency (MHRA).
Find out more
How artificial intelligence is transforming eye care
Posted: Thursday 9 January 2025
Artificial intelligence (AI) is already part of our daily lives, but how is it changing healthcare? In a recent webinar hosted by Macular Society partner OcuPlan Dr James Neffendorf, an eye specialist at King’s College Hospital and ophthalmic surgeon Dan Calladine, explored how AI is transforming the way eye care is delivered and how it is improving outcomes for patients.
Find out more
Daily tablet shows promise as first treatment for Stargardt disease
Posted: Monday 2 December 2024
A new drug for Stargardt disease, called gildeuretinol (ALK-001), has received special recognition from the Food and Drug Administration in the US, highlighting its potential to treat the condition.
Find out more
First-of-a-kind study shines light on DMO treatment among diverse backgrounds
Posted: Friday 29 November 2024
For the first time, people from underrepresented ethnic and racial backgrounds were the focus of a clinical trial which reported improved vision after receiving treatment for diabetic macular oedema (DMO).
Find out more
Supplements offer hope for advanced AMD, says researcher
Posted: Monday 25 November 2024
Dr Tiarnan Keenan, a clinician scientist at the National Eye Institute in the US, shares groundbreaking insights into the benefits of AREDS2 supplements for people with geographic atrophy (GA), an advanced stage of dry age-related macular degeneration (AMD).
Find out more
First UK hearing and sight loss survey launched
Posted: Thursday 7 November 2024
The first survey in the UK to collect data on vision and hearing loss has been launched. The UK National Eye Health and Hearing Study, aims to record data to inform the NHS and policymakers and is a collaboration between sensory loss charities, Anglia Ruskin University, eye and hearing care professionals and the public sector.
Find out more
“Fundraising for research is a really integral part of what we should be doing”
Posted: Wednesday 23 October 2024
The Newmedica team swapped the clinic for the great outdoors, battling the dark, wind and rain in their efforts to raise vital funds for research to find a cure.
Find out more
Half of UK adults expect vision loss within a decade, yet many skipping eye tests
Posted: Thursday 17 October 2024
A recent survey of over 2,000 UK adults found that half of people expect to experience some form of sight loss within the next decade, yet more than a quarter do not have regular eye tests.
Find out more
World Sight Day: Myopia becoming a major global issue
Posted: Thursday 10 October 2024
Myopia, also known as short sightedness, is becoming a major global issue with new research showing one in three children is affected. In a recent My Macular and Me webinar Dr Annegret Dahlmann-Noor, called for increased awareness and research investment in MMD, which she called an "increasingly common problem."
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter